IBDEI34A ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,49787,1,3,0)
 ;;=3^Allergic Rhinitis,Unspec
 ;;^UTILITY(U,$J,358.3,49787,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,49787,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,49788,0)
 ;;=I48.0^^193^2482^7
 ;;^UTILITY(U,$J,358.3,49788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49788,1,3,0)
 ;;=3^Atrial Fibrillation Paroxysmal (PAF)
 ;;^UTILITY(U,$J,358.3,49788,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,49788,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,49789,0)
 ;;=N18.1^^193^2482^9
 ;;^UTILITY(U,$J,358.3,49789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49789,1,3,0)
 ;;=3^CKD,Stage 1
 ;;^UTILITY(U,$J,358.3,49789,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,49789,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,49790,0)
 ;;=N18.2^^193^2482^10
 ;;^UTILITY(U,$J,358.3,49790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49790,1,3,0)
 ;;=3^CKD,Stage 2
 ;;^UTILITY(U,$J,358.3,49790,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,49790,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,49791,0)
 ;;=N18.3^^193^2482^11
 ;;^UTILITY(U,$J,358.3,49791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49791,1,3,0)
 ;;=3^CKD,Stage 3
 ;;^UTILITY(U,$J,358.3,49791,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,49791,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,49792,0)
 ;;=N18.4^^193^2482^12
 ;;^UTILITY(U,$J,358.3,49792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49792,1,3,0)
 ;;=3^CKD,Stage 4
 ;;^UTILITY(U,$J,358.3,49792,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,49792,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,49793,0)
 ;;=N18.5^^193^2482^13
 ;;^UTILITY(U,$J,358.3,49793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49793,1,3,0)
 ;;=3^CKD,Stage 5
 ;;^UTILITY(U,$J,358.3,49793,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,49793,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,49794,0)
 ;;=N18.6^^193^2482^24
 ;;^UTILITY(U,$J,358.3,49794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49794,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,49794,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,49794,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,49795,0)
 ;;=E11.22^^193^2482^20
 ;;^UTILITY(U,$J,358.3,49795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49795,1,3,0)
 ;;=3^DM Type 2 w/ CKD
 ;;^UTILITY(U,$J,358.3,49795,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,49795,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,49796,0)
 ;;=E11.319^^193^2482^22
 ;;^UTILITY(U,$J,358.3,49796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49796,1,3,0)
 ;;=3^DM Type 2 w/ Retinopathy Unspec w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,49796,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,49796,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,49797,0)
 ;;=G40.909^^193^2482^74
 ;;^UTILITY(U,$J,358.3,49797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49797,1,3,0)
 ;;=3^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,49797,1,4,0)
 ;;=4^G40.909
 ;;^UTILITY(U,$J,358.3,49797,2)
 ;;=^5003865
 ;;^UTILITY(U,$J,358.3,49798,0)
 ;;=N52.9^^193^2482^28
 ;;^UTILITY(U,$J,358.3,49798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49798,1,3,0)
 ;;=3^Erectile Dysfuntion,Unspec
 ;;^UTILITY(U,$J,358.3,49798,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,49798,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,49799,0)
 ;;=I50.22^^193^2482^37
 ;;^UTILITY(U,$J,358.3,49799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49799,1,3,0)
 ;;=3^Heart Failure,Systolic,Chronic
 ;;^UTILITY(U,$J,358.3,49799,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,49799,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,49800,0)
 ;;=I50.32^^193^2482^35
